Pertussis vaccination programme for pregnant women

The pregnancy programme has been in place since 1 October 2012 and has been shown to be very safe and effective in protecting babies against serious disease until they can have their first vaccine at two months of age.

The vaccination also protects the mother who cannot then infect her baby.
 
A study of 20 000 vaccinated women by the Medicines and Healthcare Products Regulatory Agency found no evidence of risks to pregnancy.  
The vaccine is routinely offered during pregnancy in the United States and New Zealand.
 
Vaccinations against pertussis should be offered to all pregnant women between 28 and 38 weeks of pregnancy (ideally between 28 and 32 weeks inclusive) unless immunisation is contraindicated.  There are very few individuals who cannot receive pertussis-containing vaccines.